Terminology Service for NFDI4Health
JSON

Ipilimumab/Nivolumab Regimen

Go to external page http://purl.obolibrary.org/obo/NCIT_C154272

A regimen consisting of ipilimumab and nivolumab that can be used for the treatment of kidney cancer, colorectal cancer and melanoma. [ ]

Term info

Label

Ipilimumab/Nivolumab Regimen

Synonyms
  • Ipilimumab + Nivolumab
  • Ipilimumab Plus Nivolumab
  • Ipilimumab-Nivolumab
  • Ipilimumab/Nivolumab
  • Ipilimumab/Nivolumab Regimen
  • Nivolumab/Ipilimumab
Subsets

NCIT_C160952, NCIT_C160950

Accepted Therapeutic Use For

untreated advanced renal cell carcinoma; microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC)

NCI META CUI

CL555273

Preferred Name

Ipilimumab/Nivolumab Regimen

Semantic Type

Therapeutic or Preventive Procedure

code

C154272